Literature DB >> 17335077

Studies of the central nervous system-derived CAD cell line, a suitable model for intraneuronal transport studies?

Yongling Li1, Linda Xiu-E Hou, Annika Aktiv, Annica Dahlström.   

Abstract

The CAD cell line is a variant of a CNS-derived Cath.a cell line established by targeted oncogenesis in transgenic mice. Cell differentiation of the cell line can be induced by "starvation," i.e., removal of serum from the culture medium (protein-free medium). The differentiated CAD cells extend long processes, which ultrastructurally contain abundant microtubules, intermediate filaments, and various synaptic vesicles/organelles in the varicose enlargements, thus resembling neurites. Histochemical studies demonstrated that the differentiated cells express a number of synaptic vesicle proteins, cytoskeletons, different neurotransmitter enzymes, neuropeptides, and glia proteins. The data suggest that the differentiated CAD cells may be a suitable model for studies of intraneuronal transport, recycling of receptors, and pharmacological investigations. (c) 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17335077     DOI: 10.1002/jnr.21216

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  14 in total

1.  Coordinated regulation of neuronal mRNA steady-state levels through developmentally controlled intron retention.

Authors:  Karen Yap; Zhao Qin Lim; Piyush Khandelia; Brad Friedman; Eugene V Makeyev
Journal:  Genes Dev       Date:  2012-06-01       Impact factor: 11.361

2.  Glucocorticoids differentially regulate the expression of CRFR1 and CRFR2α in MIN6 insulinoma cells and rodent islets.

Authors:  M O Huising; A P Pilbrow; M Matsumoto; T van der Meulen; H Park; J M Vaughan; S Lee; W W Vale
Journal:  Endocrinology       Date:  2010-11-24       Impact factor: 4.736

3.  Angiotensin II-induced upregulation of AT(1) receptor expression: sequential activation of NF-kappaB and Elk-1 in neurons.

Authors:  Amit K Mitra; Lie Gao; Irving H Zucker
Journal:  Am J Physiol Cell Physiol       Date:  2010-06-16       Impact factor: 4.249

4.  Sec24- and ARFGAP1-dependent trafficking of GABA transporter-1 is a prerequisite for correct axonal targeting.

Authors:  Veronika Reiterer; Susanne Maier; Harald H Sitte; Alexander Kriz; Markus A Rüegg; Hans-Peter Hauri; Michael Freissmuth; Hesso Farhan
Journal:  J Neurosci       Date:  2008-11-19       Impact factor: 6.167

5.  Angiotensin II causes imbalance between pro- and anti-inflammatory cytokines by modulating GSK-3β in neuronal culture.

Authors:  Deepmala Agarwal; Rahul B Dange; Mohan K Raizada; Joseph Francis
Journal:  Br J Pharmacol       Date:  2013-06       Impact factor: 8.739

6.  The serotonin transporter is an exclusive client of the coat protein complex II (COPII) component SEC24C.

Authors:  Sonja Sucic; Ali El-Kasaby; Oliver Kudlacek; Subhodeep Sarker; Harald H Sitte; Philippe Marin; Michael Freissmuth
Journal:  J Biol Chem       Date:  2011-03-17       Impact factor: 5.157

7.  A Novel Methodology Using Dexamethasone to Induce Neuronal Differentiation in the CNS-Derived Catecholaminergic CAD Cells.

Authors:  Ekkaphot Khongkla; Kwanchanok Uppakara; Nittaya Boonmuen; Kanit Bhukhai; Witchuda Saengsawang
Journal:  Cell Mol Neurobiol       Date:  2021-05-31       Impact factor: 4.231

8.  An ESCRT/VPS4 Envelopment Trap To Examine the Mechanism of Alphaherpesvirus Assembly and Transport in Neurons.

Authors:  Jenna Barnes; Bryen A Jordan; Duncan W Wilson
Journal:  J Virol       Date:  2022-01-19       Impact factor: 6.549

9.  CPAP is required for cilia formation in neuronal cells.

Authors:  Kuo-Sheng Wu; Tang K Tang
Journal:  Biol Open       Date:  2012-04-24       Impact factor: 2.422

10.  Differential regulation of the serotonin transporter by vesicle-associated membrane protein 2 in cells of neuronal versus non-neuronal origin.

Authors:  Heidi Kaastrup Müller; Marie Kragballe; Anja Winther Fjorback; Ove Wiborg
Journal:  PLoS One       Date:  2014-05-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.